Cargando…

Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)

BACKGROUND: Ovarian clear cell carcinoma is a distinct histologic subtype with grave survival. The underlying molecular mechanism is not fully elucidated. However, we don’t have many cell lines, which are useful experimental tools for research. We describe the establishment and characterization of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Ye, Shuang, Xiang, Libing, Yang, Wentao, He, Tiancong, Pei, Xuan, Guo, Lin, Yang, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038259/ https://www.ncbi.nlm.nih.gov/pubmed/29986747 http://dx.doi.org/10.1186/s13048-018-0429-5

Ejemplares similares

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2020)

Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma
por: Ye, Shuang, et al.
Publicado: (2017)

Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival
por: Ye, Shuang, et al.
Publicado: (2023)

Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
por: Ye, Shuang, et al.
Publicado: (2020)

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
por: Xiang, Libing, et al.
Publicado: (2016)

Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

Mutational analysis of KRAS and its clinical implications in cervical cancer patients
por: Jiang, Wei, et al.
Publicado: (2018)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
por: Chen, Wei, et al.
Publicado: (2021)

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
por: Jiang, Wei, et al.
Publicado: (2018)

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
por: Chen, Wei, et al.
Publicado: (2020)

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients
por: Ye, Shuang, et al.
Publicado: (2022)

Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell Line
por: Ruibin, Jiang, et al.
Publicado: (2018)

Whole-exome mutational landscape and molecular marker study in mucinous and clear cell ovarian cancer cell lines 3AO and ES2
por: Li, Jianxiong, et al.
Publicado: (2023)

Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients
por: Wu, Yutuan, et al.
Publicado: (2020)

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients
por: Tan, Xiaojie, et al.
Publicado: (2013)

Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary
por: Yamada, Takashi, et al.
Publicado: (2016)

Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy
por: Li, Mengjiao, et al.
Publicado: (2017)

Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features
por: Ye, Shuang, et al.
Publicado: (2022)

Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines
por: Zhang, Yanhua, et al.
Publicado: (2019)

Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
por: Ge, Huijuan, et al.
Publicado: (2021)

Establishment and characterization of an immortalized epithelial cell line from human gallbladder
por: Wang, Ziyi, et al.
Publicado: (2022)

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
por: Tudrej, Patrycja, et al.
Publicado: (2018)

Establishment and Characterization of a Novel Multidrug Resistant Human Ovarian Cancer Cell Line With Heterogenous MRP7 Overexpression
por: Wang, Jing-Quan, et al.
Publicado: (2021)

Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression
por: Bahar, Entaz, et al.
Publicado: (2020)

Biological characteristics of side population cells in a self-established human ovarian cancer cell line
por: WEI, ZHENTONG, et al.
Publicado: (2016)

Establishment and characterization of an immortalized epicardial cell line
por: Jiang, Haobin, et al.
Publicado: (2021)

Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line—IPO43
por: Silva, Fernanda, et al.
Publicado: (2022)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
por: Li, Fenglin, et al.
Publicado: (2022)

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
por: Franklin, Miriam, et al.
Publicado: (2018)

Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)

Establishment and characterization of human neuroblastoma and ganglioneuroblastoma cell lines.
por: Morrison, L. J., et al.
Publicado: (1982)

Establishment and Characterization of Rat Portal Myofibroblast Cell Lines
por: Fausther, Michel, et al.
Publicado: (2015)

Establishment, authenticity, and characterization of cervical cancer cell lines
por: Zuñiga Martinez, Ma de Lourdes, et al.
Publicado: (2022)

Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines
por: Cho, Chang Sik, et al.
Publicado: (2022)

Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line
por: Wu, Zhuo-Xun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gcvhon1ot365ugducllnjpvbtt